ArticleFunctional & integrative genomics2026
Resolving variants of uncertain significance in neurofibromatosis: An integrated approach combining deep learning and minigene assays.
Article in Functional & integrative genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Neurofibromatosis (NF) comprises genetic disorders mainly caused by pathogenic variants, yet its phenotypic and genotypic heterogeneity complicates diagnosis. We analyzed clinical and genomic data from 97 NF patients using targeted panels, whole-exome sequencing (WES), and whole-genome sequencing (WGS) from June 2020 to October 2024. Variants were classified according to established guidelines, and their distribution across protein domains was evaluated using Bayesian multinomial logistic regression. Deep-learning prediction tools and minigene splicing assays were applied to assess variants of uncertain significance (VUS). Sixty-nine variants were identified in NF1, NF2, and LZTR1, including 22 novel ones. In NF1, pathogenic deletions were enriched in non-domain regions, while substitutions predominated in domain regions, though without phenotype-specific associations. Two of three VUS were predicted and experimentally confirmed as pathogenic. One case achieved molecular diagnosis only through WGS after negative WES results. This study expands the mutational landscape of NF genes, underscores the diagnostic advantage of WGS, and demonstrates the effectiveness of advanced predictive and functional tools for VUS interpretation.
Indexed as
Identifiers
42247039What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.